All NaturalVue Multifocal Articles
-
193Latest Myopia NewsVTI Shares Latest One-Year PROTECT Trial Data at Academy 2024
November 12, 2024 INDIANAPOLIS — At the American Academy of Optometry Meeting, Visioneering Technologies Inc. (VTI) shared new findings from Year One...
-
443Products & ServicesVTI’s Chief Medical Officer Dr. Ashley Tuan Shares PROTECT Study Data at IMC
sponsored content October 15, 2024 SANYA, Hainan Island, China – Dr. Ashley Tuan, OD, PhD, the Chief Medical Officer of Visioneering Technologies,...
-
296Latest Myopia NewsVTI Presents Latest PROTECT Trial Data at Myopia Conferences
October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT...
-
631Latest Myopia NewsGelflex Named Australia and New Zealand Distributor of NaturalVue Multifocals
August 22, 2024 ATLANTA, Ga./PERTH, Australia — Visioneering Technologies Inc. (VTI) has announced Gelflex as the official distributor of its NaturalVue Multifocal...
-
1.1KPodcastsNew Data and Fitting Experience Revealed for VTI’s NaturalVue Multifocal Contact Lenses
sponsored content April 3, 2024 In this interview, Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies Inc. (VTI) sat down...
-
758Latest Myopia NewsVTI Shares Ongoing Results of One-Year PROTECT Trial
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
-
741Clinical
PROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control
sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...
-
734Products & ServicesJuan Carlos Aragón Discusses His New CEO Role at Visioneering Technologies
sponsored content October 12, 2023 At the American Academy of Optometry’s Annual Meeting, Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Dr. Juan...
-
1.1KPatient CommunicationTalking to a Myopic Adult About Risks for Their Children
October 2, 2023 By Wes McCann, OD Initiating a dialogue with a myopic adult about the risks posed to their children requires...
-
1.8KLatest Myopia NewsVTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director
ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...
-
1.1KLatest Myopia NewsVTI’s PROTECT Study Reaches 100% Enrollment
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
-
1.5KClinicalWhat Can Chicken Eyes Tell Us About Using NaturalVue Multifocals?
sponsored content August 1, 2022 By Ashley Tuan, OD, PhD, FAAO Randomized controlled chicken studies have shown relative myopic defocus from a...
-
1.1KLatest Myopia NewsTHE Myopia Meeting Returns Live In Person
May 20, 2022 COSTA MESA, Calif. — THE Myopia Meeting is back in person and returned with an all-day event here Sunday,...
-
1.4KClinical
VTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
-
1.1KLatest Myopia NewsVTI Raises $22 Million to Focus on Markets with High Rates of Myopia
February 17, 2021 ATLANTA – Visioneering Technologies, Inc. (VTI) has received investment commitments of $22 million, according to a company announcement. Capital...